Calator

Reuters – Even short-term use of popular acid-reducing heartburn drugs may raise the risk of hip fractures, U.S. researchers said on Monday.

AP – AstraZeneca PLC and Merck & Co. said Monday they will jointly develop a pair of drugs meant to hit cancer with a one-two punch, part of a growing trend of combination cancer treatments.

Reuters – The number of middle-aged and older Americans who eat right, exercise and keep their weight down has declined substantially in the past two decades, a new study finds.

Reuters – People with private health insurance lose more weight after having weight-loss surgery than those covered by the Medicare health insurance program for the elderly and disabled, U.S. researchers said Monday.

Reuters – Most preterm infants who survive a type of stroke called “periventricular hemorrhagic infarction,” or PVHI, suffer only mild functional impairment in childhood. Moreover, their average IQ is just a few points lower than that of preterm infants who do not suffer PVHI.

Reuters – Some teenagers with depression may not want treatment because they worry about the stigma attached to the disorder, a new study suggests.

Reuters – The U.S. Congress has started work on a broad overhaul of the healthcare system in a rare spirit of optimism, but brewing battles over its cost, scope and structure could still scuttle hopes for a solution.

AP – Adult survivors of childhood cancer who most need mammograms and other tests to watch for second cancers are less likely to follow screening recommendations than the general public or even their healthy siblings, a new study finds.

AFP – Low glycogen levels could explain why some people always turn aggressive or violent when they drink, a Finnish study showed Monday, suggesting the problem could be avoided with medication and regular meals.

HealthDay – SUNDAY, May 31 (HealthDay News) — Using a combination of the
drugs temsirolimus (Torisel) and Bryostatin appears to be safe in patients
with metastatic kidney cancer, according to early data from 25 patients in
a phase 1 trial.